[Form 4] Orchestra BioMed Holdings, Inc. Insider Trading Activity
Orchestra BioMed director David Pacitti was awarded 15,000 restricted stock units (RSUs) on 08/07/2025. Each RSU represents a contingent right to receive one share of common stock and the RSUs vest on the one-year anniversary of the grant, subject to the reporting person's continuous service through that date.
Following the award, the reporting person beneficially owns 44,968 shares of common stock in a direct ownership form. The RSUs carry no stated cash price and will convert to shares upon vesting.
Il direttore di Orchestra BioMed David Pacitti ha ricevuto 15.000 unit脿 di azioni vincolate (RSU) in data 08/07/2025. Ciascuna RSU rappresenta un diritto condizionato a ricevere una azione ordinaria e le RSU maturano nel primo anniversario della concessione, subordinatamente alla continuit脿 del servizio della persona che effettua la segnalazione fino a quella data.
Successivamente all'assegnazione, la persona che segnala possiede beneficiariamente 44.968 azioni ordinarie in forma di propriet脿 diretta. Le RSU non prevedono un prezzo in contanti dichiarato e si convertiranno in azioni al momento della maturazione.
El director de Orchestra BioMed David Pacitti 谤别肠颈产颈贸 15.000 unidades restringidas de acciones (RSU) el 08/07/2025. Cada RSU representa un derecho condicionado a recibir una acci贸n ordinaria, y las RSU se consolidan en el primer aniversario de la concesi贸n, sujeto a que la persona informante mantenga servicio continuo hasta esa fecha.
Tras la adjudicaci贸n, la persona informante posee beneficiariamente 44.968 acciones ordinarias en forma de propiedad directa. Las RSU no tienen un precio en efectivo establecido y se convertir谩n en acciones al consolidarse.
Orchestra BioMed鞚� 鞚挫偓 David Pacitti电� 15,000臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSUs)毳� 08/07/2025鞐� 靾橃棳氚涭晿鞀惦媹雼�. 臧� RSU电� 氤错喌欤� 1欤茧ゼ 氚涭潉 靾� 鞛埖鐢 臁瓣贝攵� 甓岆Μ毳� 鞚橂頃橂┌, RSU电� 靾橃棳鞚茧攵�韯� 1雲勳Ц 霅樀鐢 雮犾棎 旆摑(vesting)霅橂┌ 頃措嫻 鞚缄箤歆� 氤搓碃鞚胳澊 瓿勳啀 攴茧頃橁碃 鞛堨柎鞎� 頃╇媹雼�.
靾橃棳 頉� 氤搓碃鞚胳潃 鞁れ鞝侅溂搿� 44,968欤检潣 氤错喌欤茧ゼ 歆侅为 氤挫湢頃橁碃 鞛堨姷雼堧嫟. RSU鞐惖鐢 氇呾嫓霅� 順勱笀 臧�瓴╈澊 鞐嗢溂氅�, 旆摑 鞁� 欤检嫕鞙茧 鞝勴櫂霅╇媹雼�.
Le directeur d'Orchestra BioMed, David Pacitti, s'est vu attribuer 15 000 unit茅s d'actions restreintes (RSU) le 08/07/2025. Chaque RSU repr茅sente un droit conditionnel 脿 recevoir une action ordinaire, et les RSU sont acquises 脿 la date du premier anniversaire de l'attribution, sous r茅serve que la personne d茅clarante conserve son emploi jusqu'脿 cette date.
Apr猫s cette attribution, la personne d茅clarante d茅tient 脿 titre b茅n茅ficiaire 44 968 actions ordinaires en propri茅t茅 directe. Les RSU n'ont pas de prix en esp猫ces indiqu茅 et seront converties en actions lors de leur acquisition.
Der Direktor von Orchestra BioMed, David Pacitti, wurde am 08/07/2025 mit 15.000 Restricted Stock Units (RSUs) ausgezeichnet. Jede RSU begr眉ndet einen bedingten Anspruch auf den Erhalt einer Stammaktie, und die RSUs werden am ersten Jahrestag der Zuteilung f盲llig, vorbehaltlich der durchgehenden Dienstzeit der meldenden Person bis zu diesem Datum.
Nach der Zuteilung besitzt die meldende Person wirtschaftlich 44.968 Stammaktien in direktem Eigentum. Die RSUs haben keinen festgelegten Barwert und werden bei F盲lligkeit in Aktien umgewandelt.
- None.
- None.
Insights
TL;DR: A routine 15,000-RSU director grant; limited near-term market impact and increases potential share issuance on vesting.
The Form 4 reports an acquisition-style award of 15,000 RSUs to director David Pacitti, each representing one share and vesting one year after the grant subject to continued service. The report also shows 44,968 shares beneficially owned directly after the award. This is a standard equity compensation mechanism rather than a cash transaction; its materiality depends on total outstanding shares, which is not provided in this filing. No derivative transactions are reported.
TL;DR: Vesting RSUs align director incentives with shareholders but appear to be routine board compensation, not a governance red flag.
The award vests after one year and is conditioned on continuous service, which is a common retention and alignment tool. The direct beneficial ownership figure of 44,968 shares is disclosed, clarifying the director's reported stake. There is no indication of accelerated vesting, related-party cash payments, or unusual derivative activity in this filing.
Il direttore di Orchestra BioMed David Pacitti ha ricevuto 15.000 unit脿 di azioni vincolate (RSU) in data 08/07/2025. Ciascuna RSU rappresenta un diritto condizionato a ricevere una azione ordinaria e le RSU maturano nel primo anniversario della concessione, subordinatamente alla continuit脿 del servizio della persona che effettua la segnalazione fino a quella data.
Successivamente all'assegnazione, la persona che segnala possiede beneficiariamente 44.968 azioni ordinarie in forma di propriet脿 diretta. Le RSU non prevedono un prezzo in contanti dichiarato e si convertiranno in azioni al momento della maturazione.
El director de Orchestra BioMed David Pacitti 谤别肠颈产颈贸 15.000 unidades restringidas de acciones (RSU) el 08/07/2025. Cada RSU representa un derecho condicionado a recibir una acci贸n ordinaria, y las RSU se consolidan en el primer aniversario de la concesi贸n, sujeto a que la persona informante mantenga servicio continuo hasta esa fecha.
Tras la adjudicaci贸n, la persona informante posee beneficiariamente 44.968 acciones ordinarias en forma de propiedad directa. Las RSU no tienen un precio en efectivo establecido y se convertir谩n en acciones al consolidarse.
Orchestra BioMed鞚� 鞚挫偓 David Pacitti电� 15,000臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSUs)毳� 08/07/2025鞐� 靾橃棳氚涭晿鞀惦媹雼�. 臧� RSU电� 氤错喌欤� 1欤茧ゼ 氚涭潉 靾� 鞛埖鐢 臁瓣贝攵� 甓岆Μ毳� 鞚橂頃橂┌, RSU电� 靾橃棳鞚茧攵�韯� 1雲勳Ц 霅樀鐢 雮犾棎 旆摑(vesting)霅橂┌ 頃措嫻 鞚缄箤歆� 氤搓碃鞚胳澊 瓿勳啀 攴茧頃橁碃 鞛堨柎鞎� 頃╇媹雼�.
靾橃棳 頉� 氤搓碃鞚胳潃 鞁れ鞝侅溂搿� 44,968欤检潣 氤错喌欤茧ゼ 歆侅为 氤挫湢頃橁碃 鞛堨姷雼堧嫟. RSU鞐惖鐢 氇呾嫓霅� 順勱笀 臧�瓴╈澊 鞐嗢溂氅�, 旆摑 鞁� 欤检嫕鞙茧 鞝勴櫂霅╇媹雼�.
Le directeur d'Orchestra BioMed, David Pacitti, s'est vu attribuer 15 000 unit茅s d'actions restreintes (RSU) le 08/07/2025. Chaque RSU repr茅sente un droit conditionnel 脿 recevoir une action ordinaire, et les RSU sont acquises 脿 la date du premier anniversaire de l'attribution, sous r茅serve que la personne d茅clarante conserve son emploi jusqu'脿 cette date.
Apr猫s cette attribution, la personne d茅clarante d茅tient 脿 titre b茅n茅ficiaire 44 968 actions ordinaires en propri茅t茅 directe. Les RSU n'ont pas de prix en esp猫ces indiqu茅 et seront converties en actions lors de leur acquisition.
Der Direktor von Orchestra BioMed, David Pacitti, wurde am 08/07/2025 mit 15.000 Restricted Stock Units (RSUs) ausgezeichnet. Jede RSU begr眉ndet einen bedingten Anspruch auf den Erhalt einer Stammaktie, und die RSUs werden am ersten Jahrestag der Zuteilung f盲llig, vorbehaltlich der durchgehenden Dienstzeit der meldenden Person bis zu diesem Datum.
Nach der Zuteilung besitzt die meldende Person wirtschaftlich 44.968 Stammaktien in direktem Eigentum. Die RSUs haben keinen festgelegten Barwert und werden bei F盲lligkeit in Aktien umgewandelt.
FAQ
What transaction was reported on the OBIO Form 4 by David Pacitti?
How many OBIO shares does the reporting person beneficially own after the transaction?
What is the vesting schedule for the RSUs reported on the OBIO Form 4?
Did the Form 4 report any derivative securities or option exercises for OBIO?
Who is the reporting person and what is their relationship to OBIO?
